CareDx Inc
General ticker "CDNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.3B
CareDx Inc follows the US Stock Market performance with the rate: 52.1%.
Estimated limits based on current volatility of 2.8%: low 20.11$, high 21.26$
Factors to consider:
- Current price 33.9% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.37$, 16.00$]
- 2024-12-30 to 2025-12-30 estimated range: [8.22$, 18.95$]
Financial Metrics affecting the CDNA estimates:
- Negative: Non-GAAP EPS, $ of -0.64 <= 0.10
- Negative: Operating profit margin, % of -42.04 <= 1.03
- Negative: Operating cash flow per share per price, % of -3.22 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Interest expense per share, $ of 0 <= 0
Short-term CDNA quotes
Long-term CDNA plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $296.40MM | $321.79MM | $280.32MM |
Operating Expenses | $326.12MM | $399.02MM | $483.69MM |
Operating Income | $-29.73MM | $-77.23MM | $-203.36MM |
Non-Operating Income | $-2.36MM | $1.00MM | $13.22MM |
Interest Expense | $0.00MM | $3.76MM | $0.00MM |
R&D Expense | $76.53MM | $90.39MM | $81.87MM |
Income(Loss) | $-32.09MM | $-76.23MM | $-190.14MM |
Taxes | $-1.43MM | $0.38MM | $0.14MM |
Profit(Loss) | $-30.66MM | $-76.61MM | $-190.28MM |
Stockholders Equity | $465.88MM | $430.91MM | $261.33MM |
Inventory | $17.19MM | $19.23MM | $19.47MM |
Assets | $566.62MM | $542.99MM | $466.83MM |
Operating Cash Flow | $-19.29MM | $-25.24MM | $-18.39MM |
Capital expenditure | $20.26MM | $24.33MM | $9.24MM |
Investing Cash Flow | $47.71MM | $-228.50MM | $40.45MM |
Financing Cash Flow | $185.64MM | $-4.54MM | $-29.61MM |
Earnings Per Share* | $-0.59 | $-1.44 | $-3.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.